All In MedTech

Device Trial Radar · NCT02750501

Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study

Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study in Patients With Cystic Fibrosis Receiving Enteral Feeding

Last checked: Nov 20, 2026Latest source record: Aug 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

49

Actual

Start

Jul 20, 2016

Primary completion

Mar 30, 2017

Study completion Mar 30, 2017

Sponsor

Lead sponsor
Alcresta Therapeutics, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Cystic Fibrosis Foundation
First posted
Apr 25, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 4 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Protocol 0000498: Multicenter, open label study to evaluate the effect of sustained RELiZORB (immobilized lipase) cartridge use during enteral feeding on fat absorption, as well as safety and tolerability of sustained RELiZORB use, in patients with cystic fibrosis and exocrine pancreatic insufficiency.

Conditions

  • Cystic Fibrosis

Interventions

  • RELiZORB (immobilized lipase) cartridgeDevice

    Hydrolyzing fats from enteral formula, ex vivo, with in-line enteral feed RELiZORB (immobilized lipase) cartridge

  • Impact Peptide 1.5Other

    Impact Peptide 1.5 at a volume of administration from 500 mL to 1,000 mL per enteral feeding

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline of Erythrocyte Omega-3 Index % (DHA+EPA)Time frame: Day 0 to Day 90

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Joe DiMaggio Children's Hospital / Memorial Healthcare System

    Hollywood, Florida

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.